Back

Feasibility and outcomes of pulmonary vein isolation after transcatheter tricuspid valve intervention in patients with atrial fibrillation

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation in clinical practice Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Jan-Hendrik Schipper

University of Cologne, Cologne (Germany)

6 More presentations in this session

Presentation thumbnail
A multi-center study comparing leadless pacemaker vs. standard pacemaker in patients with indication to ablate and pace for atrial fibrillation (LEAD-AP)
Doctor I. Overeinder (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Non-invasive characterization of atrial cardiomyopathy using strain and selective epicardial adipose tissue in persistent atrial fibrillation
Doctor A. Grosse (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Long-term persistence of superior vena cava impact following pulsed-field ablation of the right pulmonary veins
Doctor H. Matsuura (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Atrial substrate and electrogram characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy
Doctor G. Mascia (Genova, IT)
Abstract Slides Video
Presentation thumbnail
Ultra-low voltage zones as a marker of atrial cardiomyopathy: insights from high-density mapping
Doctor A. Spadotto (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation in clinical practice

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Session
Atrial fibrillation catheter ablation (1)
thumbnail
Congress Session
Fusing expertise for optimal patient outcomes
thumbnail
Congress Session
Young Investigator Award Clinical Cardiology

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources